Its expression, specifically in conjunction with AQP1 (AQP1+NPRC+), defines the RCC-HD subtype, which is strongly associated with significantly improved patient survival outcomes compared to less differentiated, higher-risk subtypes. This evidence concerns the gene AQP1 and renal cell carcinoma.